Influence of 2-chloroadenosine on the nucleotide content of isolated rat hepatocytes  by Claeyssens, Sophie et al.
Volume 232, number 2, 317-322 FEB 05855 May 1988 
Influence of 2-chloroadenosine on the nucleotide content of isolated 
rat hepatocytes 
Sophie Claeyssens, Michkle Hamet + , Arlette Chedeville, Jean-Pierre Basuyau and Alain Lavoinne 
Groupe de Biochimie et de Physiopathologie Digestive et Nutritionnelle, UER Mdecine et Pharmacie a’e Rouen, 
Avenue de l’Universitt, BP 97, 76800 Saint Etienne du Rouvray and ‘INSERM U 75, FacuM de M&decine Necker-Enfants 
Malades, 156 rue de Vaugirard, 76016 Paris, France 
Received 7 March 1988 
2-Chloroadenosine is presumably a non-metabolizable analogue of adenosine; however, this compound induced an in- 
crease in the enzymatically measured nucleotide content of isolated rat hepatocytes. HPLC separation and spectral analy- 
sis of the peaks showed that this increase may be related to the formation of Z-chloro nucleotides and that the 2-chloro 
nucleotides appeared in the first minutes of the incubation period. These results demonstrate that 2chloroadenosine may 
be metabolized by phosphorylation in rat liver cells. 
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1. INTRODUCTION 
2-Chloroadenosine is a presumably non- 
metabolizable derivative of adenosine [l]. It is 
characteristic of an external Ra receptor [2-51, 
which stimulates adenylate cyclase activity and so 
increases cyclic AMP concentration. In isolated 
hepatocytes, this adenosine derivative has been 
used in metabolic studies to distinguish effects due 
to direct action of adenosine on the adenylate 
cyclase system from those caused by metaboliza- 
tion of adenosine [6-81. However, 2-chloroadeno- 
sine induces changes in gluconeogenesis and 
ketone-body release which cannot be explained by 
increased CAMP concentration: i.e. a decrease in 
gluconeogenesis from alanine or increase in 
ketone-body release in the presence of alanine or 
lactate (Lavoinne, A., unpublished). Such para- 
doxical metabolic modifications could be explain- 
ed by the metabolization of 2-chloroadenosine 
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through pathways involving either adenosine 
kinase or adenosine deaminase. 
Here, we have studied the influence of 
2-chloroadenosine on the nucleotide content of 
isolated hepatocytes. Our results demonstrate that 
2-chloroadenosine may be metabolized by rat liver 
cells via a nucleoside kinase but not adenosine 
deaminase. Hepatocytes incubated with 2-chloro- 
adenosine were found to contain 2-chloro-ADP 
and 2-chloro-ATP. 
2. MATERIALS AND METHODS 
2.1. Rats 
Male Wistar rats (200-250 g) were obtained from Charles 
River (France). Animals were fed ad libitum or starved for 24 h 
before use. 
2.2. Reagents 
Enzymes, coenzymes and adenosine were obtained from 
Boehringer Mannheim (France). 2-Chloroadenosine was from 
Sigma. Nucleotides were from Boehringer or Sigma, and Nem- 
butal from Abbott (France). Deoxycoformycin was generously 
provided by Dr H.E. Machamer (Warner-Lambert, Parke- 
Davis Pharmaceutical Research Division, Detroit, MI), 
5iodotubercidin by Professor L.B. Townsend (College of 
Pharmacy, University of Michigan, Ann Arbor, MI) and 
Published by Eisevier Science Publishers B. V. (Biomedical Division) 
00145793/88/$3.50 0 1988 Federation of European Biochemical Societies 317 














FEBSLETTERS May 1988 
b ;; 25-= = 
: 
,, 1.5 k:., ,, , , , 
0.05 0.2 0.5 0 0.05 0.2 05 o.50Lll 05 
01 0.1 0.1 
~Uclecside) (mM) p-Chloroadenosin~ (mM) 
Fig.1. Dose response of the effect of adenosine and 2-chloroadenosine on nucleoside triphosphate content in hepatocytes. (a,b) 
Hepatocytes were isolated from fed (a) or fasted (b) rats. After 20 min incubation without substrate, adenosine (m) or 
2chloroadenosine (0) was added at various concentrations and the incubation continued for 60 min. Values are means k SE for 5 
cell preparations. NTP, enzymatically measured. * Significance vs control; ’ significance for chloroadenosine vs adenosine. (c) 
Procedure as in (a). (0) Nucleoside triphosphate measured with the hexokinase reaction (NTP); (+) ATP measured using HPLC. 
Values are means for 2 cell preparations: 
R-51469 by Dr H. Van Belle (Janssen Pharmaceuticals Research 
Laboratories, Beerse, Belgium). For HPLC, ultrapure KHzP04 
from Merck was used. 
2.3. Isolated liver cells 
Preparation and incubation of isolated liver cells were per- 
formed as in [9], except that no albumin was added to the in- 
cubation medium; briefly, hepatocytes (50 mg wet wt/ml) were 
incubated for 20 min in the absence or presence of substrates 
before addition of effector( 
All results are expressed as means + SE. Statistical 
significance of differences was assessed by Student’s paired t- 
test with P < 0.05 taken as the threshold of probability. 
2.4. Nucleotide measurements 
Nucleoside triphosphates were measured by both enzymatic 
determination and HPLC. The hexokinase method used for the 
measurement of nucleoside triphosphate is not completely 
specific for ATP [lo] and we use here the term ‘nucleoside 
triphosphate’ (NTP) rather than ATP for this enzymatic deter- 
mination. HPLC (Waters) was performed as described [l l] us- 
ing 20 mM KH~P04/40 mM KC1 (pH 3.8) as the initial eluant 
and 250 mM KH~P04/500 mM KC1 (pH 5.1) as final eluant. 
The column packing used was SAX10 (Waters Associates). In- 
tegration of peak areas was automatically effected by an 
ICAP- (Delsi) integrator. 
3. RESULTS AND DISCUSSION 
2-Chloroadenosine induced an increase in 
nucleoside triphosphate (NTP) content of isolated 
Table 1 
Influence of nucleoside transporter and adenosine kinase inhibitors on the 2-chloroadenosine ffect on nucleotide content in 
hepatocytes from fed rats 
Control + Ado + 2-ClAdo 
(0.1 mM) (0.1 mM) 
Control 
+ R-5 1469 + Uodotubercidin 
+ Ado + 2-ClAdo Control + 2-ClAdo 
(0.1 mM) (0.1 mM) (0.1 mM) 
NTP 
content 
@mol/g) 2.03 * 0.18 2.44= + 0.17 2.31a * 0.20 1.76 f 0.18 1.74 f 0.20 1.67 + 0.22 1.97 f 0.18 1.90 + 0.19 
a Significance vs control 
After 20 min incubation without substrate, effecters were added for 30 min: 0.5 mM R51469, an inhibitor of the nucleoside 
transporter; 10 ,uM 5-iodotubercidin, an adenosine kinase inhibitor. Values are means for 4 cell preparations 
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hepatocytes (fig. la) and chloroadenosine in the 
range 0.1-0.2 mM was more effective than 
adenosine at increasing NTP content. This increase 
in NTP was also observed in hepatocytes isolated 
from fasted rats (fig.lb) and appeared in the 
presence of various energetic substrates such as 
glucose or pyruvate (not shown). Therefore, the ef- 
feet of 2-chloroadenosine on the NTP content of 
hepatocytes was independent of the nutritional 
status of the animals. 
Using R-51469, a compound which is known to 
inhibit adenosine transport in hepatocytes [6], the 
effect of both nucleosides (adenosine and 
2-chloroadenosine) on NTP content was sup- 
pressed (table 1). This result suggested that 
2-chloroadenosine may enter hepatocytes using the 
nucleoside transporter as described for human 
erythrocytes [12]. Moreover, this increase in NTP 
content was suppressed by 5-iodotubercidin, an in- 
hibitor of adenosine kinase [13,14] (table l), sug- 
gesting metabolism of 2xhloroadenosine through 
adenosine kinase. However, because of the low 
ADP 3 
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Fig.2. HPLC separation of the nucleotide content in hepatocytes incubated with adenosine or 2-chloroadenosine. Experimental 
procedure as in fig.la. (a) 0.1 mM adenosine; (b) 0.1 mM 2-chloroadenosine. Supplementary peaks are indicated by an arrow. 
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Fig.3. Dose response of the effect of 0.1 mM 2-chloroadenosine 
on the formation of 2-chloro-ADP and 2-chloro-ATP in 
hepatocytes. Experimental procedure as in fig.la. (A) 
2-Chloro-ADP; (A) 2-chloro-ATP. Values are means for 2 cell 
preparations. 
specificity of the hexokinase reaction (see section 
2), we cannot conclude as to the nature of the 
nucleotide formed from 2-chloroadenosine. 
Separation of nucleotides using HPLC showed 
that, in contrast to adenosine, intracellular ATP 
content was not increased in the presence of 
2-chloroadenosine, but decreased (fig. lc). 
However, two new peaks were observed on the 
chromatogram in hepatocytes incubated with 
2-chloroadenosine, with retention times close to 
those of ADP and ATP (fig.2). Maximum,absorp- 
tion was found at 259 nm for adenosine and 
265 nm for 2-chloroadenosine, and absorption of 
the supplementary peaks observed after incubation 
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Fig.4. Time-course study of the influence of 0.1 mM adenosine or 2-chloroadenosine on the nucleotide content in hepatocytes. 
Experimental procedure as in fig.la. (a) (m) Adenosine; (0) 2-chloroadenosine. Control value (0 min) was 2.15 f 0.19 pmol/g cells 
for NTP. Values are means for 5 cell preparations. (b) (A) 2-Chloro-ADP; (A) 2-chloro-ATP. Values are means for 2 cell preparations. 
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of hepatocytes with 2-chloroadenosine was max- 
imal at 265 nm (spectra were recorded at the max- 
imum elution of the peak using an HP 1040 A 
spectrophotometric detector). It may thus be con- 
cluded that these peaks correspond to the forma- 
tion of I-chloro-ADP and 2-chloro-ATP, 
respectively. Moreover, the increase in NTP con- 
tent may be related to the formation of 2-chloro- 
ATP in the presence of 2-chloroadenosine (fig.3). 
Investigation of the time course clearly showed 
that the increase in NTP content was more pro- 
nounced during the initial part of the incubation 
period in the presence of adenosine than with 
2-chloroadenosine (fig.4a), which may be ex- 
plained as being due to slower metabolization of 
the latter. However, 2-chloro-ADP and 2-chloro- 
ATP were found to appear in the first minutes of 
the incubation period (fig.4b). 
In the presence of deoxycoformycin, an in- 
hibitor of adenosine deaminase [ 151, the in- 
tracellular NTP content increased (figJa), 
however, the rise in 2-chloro-ATP concentration 
was not reinforced (fig.5b). The assumption that 
2-chloroadenosine is ,a non-metabolizable ana- 
logue of adenosine is based mainly on the work of 
Clark et al. [l] who demonstrated that the 2-sub- 
stituted analogues of adenosine were insusceptible 
to enzymatic deamination in the rat. Our results 
confirmed this insusceptibility of 2-chloroadeno- 
sine to deamination in the rat but demonstrated 
that it may be metabolized by phosphorylation. 
Adenosine kinase might be responsible for the 
phosphorylation of 2-chloroadenosine, since 
5-iodotubercidin (an inhibitor of this enzyme) in- 
hibits this process. However, to our knowledge, 
there are no data concerning the specificity of this 
inhibitor with respect to nucleoside kinases; 
moreover, 2-chloroadenosine is not a substrate of 
yeast adenosine kinase 1161 and a study on the 
adenosine kinase purified from rabbit liver 
E -Chloroadenownq (mM) 
Fig.5. Influence of an inhibitor of adenosine deaminase on the 2-chloroadenosine ffect on the nucleotide triphosphate content in 
hepatocytes from fed rats. After 20 min incubation without substrate, 2-chloroadenosine f deoxycoformycin was added. (a) Influence 
on NTP content: (0) control; (m) 10 ,uM deoxycoformycin. + Significance vs control. (b) Influence on 2-chloro-ATP content: (A) 
control; (A) 10 FM deoxycoformycin. Values are means for 2 cell preparations. 
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reported a substrate efficiency of 250 for 
adenosine and 0.003 for 2-chloroadenosine [17]. 
Thus, another nucleoside kinase is probably 
responsible for phosphorylation of 2-chloro- 
adenosine. 
In conclusion, 2-chloroadenosine may be 
metabolized by phosphorylation in rat liver cells. 
The formation of 2-chloro-ATP and (or) 2-chloro- 
ADP may be responsible for the unexpected 
metabolic changes that we have observed in the 
presence of this nucleoside. This metabolism of 
2-chloroadenosine also suggests caution in the use 
of this adenosine analogue only to stimulate the 
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